🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

225 results for “Shanghai” Clear

  1. Experimental

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Cognitive Health

    other completed

    1 trial

  2. MINGO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    X-Linked Dystonia Parkinsonism

    other completed

    1 trial

  3. Norepinephrine

    Shanghai Zhongshan Hospital

    Gastrointestinal Disease

    small molecule active

    1 trial

  4. PROGRAM

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity

    other completed

    1 trial

  5. Power Line Program

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Metabolic Health

    other completed

    1 trial

  6. Redefine

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity & Overweight

    other active

    1 trial

  7. Tianqi Pingchan Granule

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    Levodopa-Induced Dyskinesia

    small molecule active

    1 trial

  8. Usual Care

    Shanghai Jiao Tong University School of Medicine

    Hypertension

    small molecule active

    1 trial

  9. radiochemotherapy 1

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    Non Small Cell Lung Cancer

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources